The Corps of specialist Researchers that make up the Clinical Research Unit is made up of health professionals with human quality of the highest level. The doctors who belong to this unit have clinical and surgical training in ophthalmology, with university endorsement and are authorized by the General Directorate of Professions of the Ministry of Public Education and certified by the Mexican Council of Ophthalmology. All of them have training and extensive experience in clinical research from universities in the United States of America, such as Johns Hopkins and the University of Southern California. They are also part of the National System of Researchers (SNI).
Dr. Arturo Santos
Dr. Arturo Santos is a graduate of the Instituto Tecnológico y de Estudios Superiores de Monterrey where he completed his degree as a Surgeon in 1989 and obtained the professional certificate from the General Directorate of Professions of the Ministry of Public Education (DGP-SEP) and the certification by the ECFMG in 1990. In the period from 1990 to 1993, he completed his Medical Specialty in Ophthalmology at the Association to Avoid Blindness in Mexico, clinical headquarters of the Academic Program of the National Autonomous University of Mexico.
In 1993 he obtained the Certification from the Mexican Council of Ophthalmology and the authorization to practice the Ophthalmology Specialty from the DGP-SEP. From 1993 to 1995 he received additional clinical and surgical training and training in Vitreous and Retina Diseases and Surgery at the Luis Sánchez Bulnes Hospital of the Association to prevent blindness in Mexico. During 1995 to 1996, after obtaining the Gillinham-APAO scholarship and through an institutional license issued by the state of Maryland, Dr. Santos completed his clinical and surgical training in the specialty of Medical and Surgical Retina at the Wilmer Ophthalmological Institute of Johns Hopkins University School of Medicine. In 2006, he obtained the personal certificate with patent effects to practice professionally at the level of Specialty in Medical and Surgical Retina issued by the DGP-SEP. In 2002, by means of the doctoral thesis entitled “Genetic polymorphisms of apolipoprotein E and the severity of diabetic macular edema”, Dr. Santos obtained a Doctor of Science degree from the University of Guadalajara, after the completion of the Biology Doctorate Program Molecular in Medicine.
Currently Dr. Santos is the Director of the Medical School of the ITESM Guadalajara campus, has a desirable profile-PROMEP and is a Level II member of the SNI-CONACYT National System of Researchers. Likewise, it actively participates in the specialty program in Medical and Surgical Retina at the University of Guadalajara, which is part of the SEP-CONACYT National Postgraduate Quality Register.
Dr. Arturo Santos serves as Director General of the Center for Medical and Surgical Retina and as President of the Mexican Retina Foundation and of the College of Specialists in Medical and Surgical Retina of the State of Jalisco.
MAIN AREAS OF INTEREST
Advanced surgical techniques in vitreous-retinal disorders
-25 gauge instrumentation
-Retinal-based visual prosthesis
Molecular biology in vitreous-retinal disorders
-Genetic polymorphisms as a risk factor in diabetic retinopathy
Age-related macular degeneration
-Concomitant therapy in the treatment of NVC associated with AMD
-Intra-ocular brachytherapy in the treatment of CNV
Dr. Juan Carlos Altamirano is a graduate of the University of Guadalajara where he completed his degree as a Surgeon in 2002 and obtained a professional certificate from the General Directorate of Professions of the Ministry of Public Education (DGP-SEP) in the same year. In the period from 2003 to 2006 he completed his medical specialty in Ophthalmology at the Old Civil Hospital of Guadalajara, clinical headquarters of the Academic Program of the University of Guadalajara. In 2006 he obtained certification from the Mexican Council of Ophthalmology and authorization to practice the specialty of Ophthalmology by the DGP-SEP.
During 2006 to 2008, Dr. Altamirano carried out the specialty of Medical and Surgical Retina in the double degree program of the University of Guadalajara at the Doheny Institute of the Keck School of Medicine, University of Southern California, where he made a stay in artificial vision research. Likewise, he obtained a professional certificate to exercise the specialty in Medical and Surgical Retina in 2008.
Currently, Dr. Altamirano is the Medical Director of the Medical and Surgical Retina Center of the Puerta de Hierro Medical Center and serves as the Director of the Medical Surgeon Career at the Tec de Monterrey Campus Guadalajara.
In addition, he is the Secretary General of the College of Specialists in Medical Retina of the State of Jalisco. His areas of interest and lines of research are tummy tuck surgery, and molecular biology applied to vitreous-retinal disorders.
Dr. Juan Carlos Altamirano
Dr. Alejandro González de la Rosa
Dr. Alejandro González de la Rosa, a specialist in Medical and Surgical Retina, completed his undergraduate studies at the University of Guadalajara. He was graduated as a Surgeon and Midwife Physician in 2008. He subsequently completed his postgraduate studies in Ophthalmology at the University of Guadalajara at the National Medical Center of the West, having concluded in 2012.
From 2012 to 2014, Dr. González de la Rosa specialized in Medical and Surgical Retina in the double degree program at the University of Guadalajara and at the Doheny Institute of the Keck School of Medicine of the University of Southern California ( USC, Los Angeles, CA.). It is there where he participated in artificial vision research projects (ARGUS II), intraocular medication prolonged-release microelectronic devices (Replenish Micropump, Replenish Inc.), development of appetite suppression devices (Slim Stim, SlimStim Beverly Hills, CA), development of accommodative intraocular lenses (1Co Inc, Pasadena, CA) and prolonged intradermal drug delivery devices (MedPatch Inc, Pasadena, CA).
Currently, Dr. González De la Rosa is about to conclude his Doctorate in Clinical Research from the Monterrey Institute of Technology and Higher Studies in the line of research on hereditary atrophic diseases of the retina.
-Minimally invasive vitreomacular surgery
-Macular Surgery (Epiretinal Membrane, Macular Hole)
-Age-Related Macular Degeneration
-Diabetic Retinopathy and Diabetic Macular Edema
-Atrophic Macular Diseases
Surgeon and midwife doctor from the University of Guadalajara, a specialist in Ophthalmology and a sub-specialist in Glaucoma and Doctor in Molecular Biology in Medicine from the same University of Guadalajara. Member of the National System of Researchers, Level I. Author and co-author of different scientific publications related to molecular biology, genetics, and the clinic of ophthalmological disorders. Research Professor at the Tecnológico de Monterrey campus Guadalajara. He is currently developing the line of investigation of molecular markers of damage in glaucoma and the line of pharmacological modulation of ocular fibrosis and glaucoma.
1997-2003 SURGEON PHYSICIAN from the University of Guadalajara. Degree modality: Outstanding Academic Performance. Date of professional examination: August 25, 2003. Certificate: 4363362.
2003-2008 DOCTORATE IN MOLECULAR BIOLOGY IN MEDICINE from the University of Guadalajara. Degree modality: Thesis. Reception work evaluation date: April 20, 2010. Opinion: APPROVED.
2009-2012 MEDICAL-SURGICAL SPECIALTY IN OPHTHALMOLOGY from the University of Guadalajara. Campus; Mexican Institute of Social Security, National Medical Center of the West. Degree modality: Thesis. Opinion: APPROVED. ID: 8129461.
He is currently a member of the editorial committee of the periodic publication “Archivos de Ciencia”. Official Publication of the University Center for Health Sciences. University of Guadalajara. January 2009 and to date. Volumes 1-4.
And also, it has the recognition as NATIONAL LEVEL I INVESTIGATOR. National System of Researchers of the National Council of Science and Technology. January 1, 2014, to December 31, 2018.